The CGGA cohort of 221 patients with glioblastoma was stratified into three groups on the basis of LOC levels and IDH mutation status—that is, IDH-wild-type LOC high (n = 106), IDH-wild-type LOC low (n = 84) and IDH mutant (n = 31). Here, IDH1 is linked to glioblastoma.